Explore our latest thought leadership, ideas, and insights on the issues that are shaping the future of business and society.
Choose a partner with intimate knowledge of your industry and first-hand experience of defining its future.
Discover our portfolio – constantly evolving to keep pace with the ever-changing needs of our clients.
Become part of a diverse collective of free-thinkers, entrepreneurs and experts – and help us to make a difference.
See our latest news, and stories from across the business, and explore our archives.
We are a global leader in partnering with companies to transform and manage their business by harnessing the power of technology.
Our number one ranked think-tank
Explore our brands
Explore our technology partners
Mei Jiang, SVP, Global Digital Innovation at Medtronic, is a serial entrepreneur with a blend of experience at both startups and corporations. Since early 2000 she has worked on and led three startups in Silicon Valley into accelerated growth and exit. Currently she is driving intrapreneurship at large enterprises and has helped many large corporations drive fundamental technology and business transformations. She started her career in product, and has led and contributed to multiple digital products’ design and incubation, including China’s early target drones (unmanned aerial target or UAT), the world’s first low-cost, high-capacity tape drives in the 1990s, the industry’s first large-scale, open, and secure big data platform, IoT, smart wearables and AI/ML, and telepresence robots in the 2010s.Medtronic is a global healthcare technology leader, with more than 90,000 people across 150 countries and revenues of $31.686 billion in fiscal year 2022.
I lead Medtronic’s digital transformation journey. My job is twofold: First, exploit what we have today by continuously expanding and optimizing our medical devices and healthcare solutions to stay relevant and competitive; and second, explore the possible to create a radically new, future-fit, and innovative global healthcare technology leader for the foreseeable future.
Our mission – to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient-monitoring systems, and more. And we take great pride in knowing that we impact the lives of two patients every second. That adds up to roughly 80 million patients per year. That sounds like a lot … but 80 million is just a small fraction of the world’s population.
We can do a lot more than doctors and devices. With advances in data and technology, including 5G, edge computing, IoT, AI/ML, immersive AR/VR, miniaturization, and robotics, among other areas, Medtronic can extend its range to a much wider demographic, not only late-stage hospitalized patients.
With a shift from Wellness Debt (patient) to Wellness Wealth (consumer), Medtronic can go from 80 million patients a year to 1 billion. To make the shift, we must be more digitally minded, creating the medical equivalent of the Apples and Amazons of the world.
“We impact the lives of two patients every second. That adds up to roughly 80 million patients per year.”
Some of the greatest advances in medical technology are unfolding right now.
Imagine a miniaturized, leadless pacemaker about the size of a large vitamin capsule, which listens “digitally” to blood flowing across a human heart. In the event of an irregular rhythm, this tiny wireless device sends an electronic signal to keep the heart pumping as it should.
For decades, patients with diabetes relied solely on bloodsugar measurement to adjust the application of insulin therapy. By using AI, we are modelling patient behavior and diet to predict the impact on their blood-sugar level at a later date to help them plan their treatment proactively.
This kind of predictive technology can also help patients living with neurodegenerative disorders. A first-of-its-kind Medtronic deep brain stimulation (DBS) device can sense and record brain signals while delivering therapy to patients with Parkinson’s disease. Now, imagine that in the futurewe could automatically adjust the stimulation levels and optimize them for each individual patient, based on their own brains and the patten of their brain activities – that is true personalization.
“Imagine a miniaturized, leadless pacemaker about the size of a large vitamin capsule, which listens “digitally” to blood flowing across a human heart.”
Let’s start with life-changing devices. Besides the world’s smallest pacemaker, we have developed a swallowable camera. For colon cancer, routine colonoscopies may not be the answer. While they’re the standard of care in the US, too many patients put them off and the guidelines for screening keep changing. Not to mention, they haven’t even become the standard of care yet in many countries outside the US. What if there was an alternative to a traditional colonoscopy? A more efficient way to screen moderate-to-low-risk individuals in everyday life, anywhere? And it was as easy to use as swallowing a multivitamin-sized pill?
Well, here comes Medtronic PillCamTM.
“A capsule you can swallow that includes an integrated camera that will take thousands of images as it works its way through your digestive tract. The images will then be downloaded by a clinician for detailed analysis.”
Now, can you also imagine a clinician having AI assistance during routine colonoscopies to scan for polyps that can be difficult to detect by the naked eye. The technology flags areas of concern independently and automatically as the clinician performs the procedure in real-time. This would be our GI GeniusTM device, which is the first of its kind to be approved by the FDA in the US.
Besides life-changing devices, we’re building new digital data and AI capability to enhance intelligent therapies, insight-driven med-tech solutions, and bigger, broader digital-health ecosystems to help lower cost, improving quality and outcomes.
The following new concepts could improve the quality of life for people around the world:
Based on statistics from early-stage venture capital investments in the past decade or so, only one out of 250 VC investments will return 50x ROI, and nearly 70% of investments lose money. The hard truth is, we can’t pick the winner.
“Good and bad ideas look exactly the same at the beginning. It will take several missteps before we can distinguish between them.”
To avoid a ‘HiPPO’ –the highest paid person’s opinion determining how we make our bets – we must take an evidence-based approach by building a robust funnel for systematic decision-making.
Here is an example of how to make better investment decision in three key dimensions, adapted from The Invincible Company by Alex Osterwalder (2020):
Avoid overengineering version 1.0. The key is rapid product iterations, delivering value in increments over months or even weeks, rather than years.
We begin by designing customer value, not specification of features and functions, into our product right from our very first prototype. We focus on technologies and products that can be matched to true, compelling market needs with adequate business cases.
A successful CINO is a customer champion, a trailblazer, a commercial officer, a broker, and a storyteller. The customer champion puts the customer first. The trailblazer assumes there’s always a different, better way to do things, and takes on the high-impact problems, the seemingly impossible. The customer champion puts the customer first. The trailblazer assumes there’s always a different, better way to do things, and takes on the high-impact problems, the seemingly impossible. The commercial officer focuses on profit, building entirely new digital lines of business. The broker links disparate silos, uniting the organization in collaboration. The storyteller creates strong, potentially emotional experiences for customers using new technologies.
“A successful CINO is a customer champion, a trailblazer, a commercial officer, a broker, and a storyteller.”
One book that inspires me is The Fearless Organization: Creating Psychological Safety in the Workplace for Learning, Innovation, and Growth by Amy C. Edmondson (2018).
She uses the expression, “Innovation is culture.” To truly innovate, a shift in culture is key to achieving ambitious strategic goals. Create a safe environment where people trust one another, do crazy things, and where risk-taking is encouraged and rewarded. Failures are readily accepted as an integral part of learning. However, we must learn how to fail small and cheap, recover fast, and pivot like a “lean startup.”
Uncover innovations that matter.
Marketing is changing – for good and for the better. Stakeholder expectations have been reset, and brands are expected to act responsibly, sustainably, and to provide real value to individuals as well as societies.
Perspectives from an array of business leaders, entrepreneurs, technologists, and academics, on how the convergence of products, software, and services heralds the next big transformation opportunity for organizations.
We examine how the COVID-19 pandemic has transformed the business landscape, accelerating the digitalization process and revolutionizing the way that we work.
A sustainable future calls for collective action, bolder leadership, and smarter technologies.
What’s the Big Idea? Why most innovations fail to scale and what to do about it.
How to prepare your organization for a quantum advantage now.
Subscribe to have the latest reports from the Capgemini Research Institute delivered direct to your inbox.
We are sorry, the form submission failed. Please try again.